Seroprevalence of cytomegalovirus infection in the United States, 1988-1994.

By Stephanie Staras, S. Dollard, Kay W. Radford, W. Flanders, R. Pass, M. Cannon. Clinical Infectious Diseases, 2006

1,045 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review (2008, background): “Infections in the immunocompetent and immunosupressed are not rare; seroprevalence for CMV worldwide ranges from ~60%–100% [1].”
Immunobiology of Human Cytomegalovirus: from Bench to Bedside (2009, background): “The seroprevalence of HCMV in the human population ranges between 30% and 90% in developed countries, with seroprevalence increasing with age (256).”
Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. (2010, methodology): “A previous nationally representative seroprevalence study of CMV infection in the United States, which used data from the National Health and Nutrition Examination Survey (NHANES) III (1988–1994), indicated that large proportions of women of reproductive age are susceptible to primary infection duri”